HbA1c Kit - Registration no. 80115310145 - Models: R1: 2 x 15 ml + R2: 1 x 10 ml + R3: 1 x 5 ml - All lots manufactured in Brazil. 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 KOVALENT DO BRASIL LTDA 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1134
  • 날짜
    2012-05-16
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    DiaSys Diagnostics Systems GmbH, Germany, forwarded the communiqué to Kovalent do Brasil Ltda., Which repacks, labels and markets the One HbA1c FS product in Brazil, stating that one of its customers observed a falsely high HbA1c value of 10, 4%, in a sample analyzed with the DiaSys brand HbA1c IS reagent (photometric analysis). As this value was unlikely, the same sample was evaluated by the HPLC method, giving a value equal to 7.5%. The investigations, to find the cause of the falsely elevated value of HbA1c when tested by photometry, resulted in the diagnosis of Severe Monoclonal Gamopathy of the patient. Gammatids are known to cause nonspecific turbidity in patient samples due to protein precipitation, and therefore interfere with photometric analysis. These are very rare cases and can not be avoided most of the time. There are no reports in the Notivisa system. Anvisa follows this action.
  • 원인
    Possibility of falsely elevated hba1c results when samples from patients with gammopathies are dosed by photometric analysis.
  • 조치
    The company has already promoted the communication to its customers and made the change in the product label, emphasizing the falsification condition by samples from patients with gamma. See attached.

Manufacturer